NICE accused of restricting treatment for eye patientsBMJ 2002; 325 doi: https://doi.org/10.1136/bmj.325.7369.852/b (Published 19 October 2002) Cite this as: BMJ 2002;325:852
- Lynn Eaton
A row has broken out in the United Kingdom over the latest proposals from the government's National Institute for Clinical Evidence (NICE) to restrict NHS funded treatments to certain groups of patients.
The Royal National Institute of the Blind (RNIB) claims that NICE's latest recommendations on treatment for age related macular degeneration (the commonest cause of central vision loss in the Western world) would condemn several thousand people to have to choose between either paying privately for treatment or losing their sight.
NICE issued its appraisal consultation document on Monday and consultation is due …
Log in using your username and password
Log in through your institution
Sign up for a free trial